SI21041B - 2,2-disubstituted 1,3-dioxolanes as antitussive agents - Google Patents
2,2-disubstituted 1,3-dioxolanes as antitussive agents Download PDFInfo
- Publication number
- SI21041B SI21041B SI200120037A SI200120037A SI21041B SI 21041 B SI21041 B SI 21041B SI 200120037 A SI200120037 A SI 200120037A SI 200120037 A SI200120037 A SI 200120037A SI 21041 B SI21041 B SI 21041B
- Authority
- SI
- Slovenia
- Prior art keywords
- compounds
- phenylpiperazin
- diol
- propane
- phenyl
- Prior art date
Links
- -1 2,2-disubstituted 1,3-dioxolanes Chemical class 0.000 title claims 3
- 239000003434 antitussive agent Substances 0.000 title 1
- 229940124584 antitussives Drugs 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract 6
- PTVWPYVOOKLBCG-UHFFFAOYSA-N 3-(4-phenyl-1-piperazinyl)propane-1,2-diol Chemical compound C1CN(CC(O)CO)CCN1C1=CC=CC=C1 PTVWPYVOOKLBCG-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000000543 intermediate Substances 0.000 claims abstract 3
- 150000001875 compounds Chemical class 0.000 claims 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- 229940095064 tartrate Drugs 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 125000001960 7 membered carbocyclic group Chemical group 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical compound C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 150000003892 tartrate salts Chemical class 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 239000008096 xylene Substances 0.000 claims 1
- PTVWPYVOOKLBCG-ZDUSSCGKSA-N levodropropizine Chemical compound C1CN(C[C@H](O)CO)CCN1C1=CC=CC=C1 PTVWPYVOOKLBCG-ZDUSSCGKSA-N 0.000 abstract 1
- 229960002265 levodropropizine Drugs 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Holo Graphy (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Fats And Perfumes (AREA)
- Liquid Crystal Substances (AREA)
- Glass Compositions (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Secondary Cells (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI001735A IT1318651B1 (it) | 2000-07-28 | 2000-07-28 | Sintesi di (+-)1,3-diossolani e loro risoluzione ottica. |
| PCT/EP2001/008305 WO2002010150A1 (en) | 2000-07-28 | 2001-07-18 | 2,2-disubstituted 1,3-dioxolanes as antitussive agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SI21041A SI21041A (sl) | 2003-04-30 |
| SI21041B true SI21041B (en) | 2005-08-31 |
Family
ID=11445592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200120037A SI21041B (en) | 2000-07-28 | 2001-07-18 | 2,2-disubstituted 1,3-dioxolanes as antitussive agents |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6916926B2 (pl) |
| EP (1) | EP1307440B1 (pl) |
| JP (1) | JP5015403B2 (pl) |
| KR (1) | KR100788532B1 (pl) |
| CN (1) | CN1216053C (pl) |
| AT (1) | ATE290533T1 (pl) |
| AU (1) | AU2001281992A1 (pl) |
| BR (1) | BR0112802A (pl) |
| CZ (1) | CZ301039B6 (pl) |
| DE (1) | DE60109299T2 (pl) |
| EE (1) | EE05159B1 (pl) |
| ES (1) | ES2237589T3 (pl) |
| HU (1) | HU229801B1 (pl) |
| IL (2) | IL153502A0 (pl) |
| IT (1) | IT1318651B1 (pl) |
| MX (1) | MXPA02012922A (pl) |
| PL (1) | PL206308B1 (pl) |
| PT (1) | PT1307440E (pl) |
| RS (1) | RS50862B (pl) |
| RU (1) | RU2269522C2 (pl) |
| SI (1) | SI21041B (pl) |
| SK (1) | SK286795B6 (pl) |
| UA (1) | UA73790C2 (pl) |
| WO (1) | WO2002010150A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1318650B1 (it) * | 2000-07-28 | 2003-08-27 | Dompe Spa | 1,3-diossolani ad attivita' antitosse. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4049660A (en) * | 1971-06-18 | 1977-09-20 | Delalande S.A. | N-substituted derivatives of 4 (N-piperazinylmethyl) spiro dibenzocycloheptadi- (or tri-) ene-5, 2-dioxolane (1,3) their method of preparation and their application in therapeutics |
| IT1210639B (it) * | 1981-02-25 | 1989-09-14 | Menarini Sas | Prodotto: 3(4-fenil1piperazinio-1-il)-1,2-propandiolo 3(teofillin-7-il)-1propansolfonato,utilizzabile in terapia,e relativo procedimento di fabbricazione |
| IT1203721B (it) * | 1983-12-29 | 1989-02-23 | Dompe Farmaceutici Spa | Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono |
| SE449516B (sv) * | 1984-10-16 | 1987-05-04 | Skf Nova Ab | Klemring med reglerbar halomkrets |
| IT1254452B (it) * | 1992-02-14 | 1995-09-25 | Dompe Farmaceutici Spa | N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli |
| IL111730A (en) * | 1993-11-29 | 1998-12-06 | Fujisawa Pharmaceutical Co | Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same |
| DE69722360T2 (de) * | 1996-06-29 | 2003-11-27 | Samjin Pharm, Co. | Piperazin-derivate und verfahren zu ihrer herstellung |
| IT1318650B1 (it) * | 2000-07-28 | 2003-08-27 | Dompe Spa | 1,3-diossolani ad attivita' antitosse. |
-
2000
- 2000-07-28 IT IT2000MI001735A patent/IT1318651B1/it active
-
2001
- 2001-07-18 KR KR1020037000943A patent/KR100788532B1/ko not_active Expired - Fee Related
- 2001-07-18 US US10/312,290 patent/US6916926B2/en not_active Expired - Fee Related
- 2001-07-18 CZ CZ20030269A patent/CZ301039B6/cs not_active IP Right Cessation
- 2001-07-18 SK SK90-2003A patent/SK286795B6/sk not_active IP Right Cessation
- 2001-07-18 SI SI200120037A patent/SI21041B/sl not_active IP Right Cessation
- 2001-07-18 JP JP2002515881A patent/JP5015403B2/ja not_active Expired - Fee Related
- 2001-07-18 PL PL361173A patent/PL206308B1/pl unknown
- 2001-07-18 WO PCT/EP2001/008305 patent/WO2002010150A1/en not_active Ceased
- 2001-07-18 HU HU0301473A patent/HU229801B1/hu not_active IP Right Cessation
- 2001-07-18 RS YUP-31/03A patent/RS50862B/sr unknown
- 2001-07-18 RU RU2003105692/04A patent/RU2269522C2/ru not_active IP Right Cessation
- 2001-07-18 MX MXPA02012922A patent/MXPA02012922A/es active IP Right Grant
- 2001-07-18 AU AU2001281992A patent/AU2001281992A1/en not_active Abandoned
- 2001-07-18 ES ES01960513T patent/ES2237589T3/es not_active Expired - Lifetime
- 2001-07-18 EE EEP200300035A patent/EE05159B1/xx not_active IP Right Cessation
- 2001-07-18 EP EP01960513A patent/EP1307440B1/en not_active Expired - Lifetime
- 2001-07-18 IL IL15350201A patent/IL153502A0/xx active IP Right Grant
- 2001-07-18 BR BR0112802-7A patent/BR0112802A/pt not_active Application Discontinuation
- 2001-07-18 UA UA2003021768A patent/UA73790C2/uk unknown
- 2001-07-18 PT PT01960513T patent/PT1307440E/pt unknown
- 2001-07-18 DE DE60109299T patent/DE60109299T2/de not_active Expired - Lifetime
- 2001-07-18 AT AT01960513T patent/ATE290533T1/de active
- 2001-07-18 CN CN018134572A patent/CN1216053C/zh not_active Expired - Fee Related
-
2002
- 2002-12-17 IL IL153502A patent/IL153502A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009509971A5 (pl) | ||
| JP2005526836A5 (pl) | ||
| SE9904850D0 (sv) | Novel process and intermediates | |
| NO20025967D0 (no) | Forkortet syntese av 3,3-diarylpropylaminderivater | |
| RU2016125459A (ru) | Способ получения хиральных 2-арилморфолинов | |
| DE3772104D1 (de) | 4(5)-substituierte imidazol-derivate und zwischenverbindungen und verfahren zu ihrer herstellung. | |
| DE60002949D1 (de) | Verfahren zur Herstellung des Neuraminidase-Inhibitoren ro-64-0796 | |
| RU96105063A (ru) | Оксатиоланы, способ их получения и содержащая их фармацевтическая композиция | |
| ATE337304T1 (de) | Neues verfahren zur herstellung einer chinolon- carbonsäure | |
| RU2003105692A (ru) | 2,2-дизамещенные 1,3-диоксоланы в качестве противокашлевых средств | |
| UY25469A1 (es) | Procedimiento para preparar sulfonamidas | |
| RU2003105691A (ru) | 1,3-диоксоланы с противокашлевой активностью | |
| JP2007530579A5 (pl) | ||
| AR036207A1 (es) | 3,5-dihidroxi-2,2-dimetil-valeroamidas protegidas para la sintesis de epotilonas y derivados, un procedimiento para su preparacion y el empleo de las mismas | |
| RU2002118101A (ru) | Способ получения {2-[4-(α-фенил-п-хлорбензил)пиперазин-1-ил]-этокси}-уксусной кислоты и новые промежуточные соединения | |
| ATE336482T1 (de) | Zwischenprodukte zur synthese von benzimidazolverbindungen und ein verfahren zu ihrer herstellung | |
| DE60219957T8 (de) | Verbessertes verfahren zur herstellung von 3-(2-(4-(6-fluor-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-on | |
| JP5015403B2 (ja) | （−）３−（４−フェニル−１−ピペラジニル）−１，２−プロパンジオール及びその中間体の製造方法 | |
| FI20030026A0 (fi) | Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita | |
| AR005237A1 (es) | Procedimiento para la preparacion de derivados de ciclopenteno condensados con anillos aromaticos, intermediarios y procedimientos para su preparacion, yderivados de ciclopenteno. | |
| ATE519745T1 (de) | Verfahren zur herstellung von vorläufern für l-3, 4-dihydroxy-6-ä18füfluor-phenylalanin und 2- ä18füfluor-l-tyrosin und deren alpha-methylierten derivaten und die vorläufer | |
| UA73789C2 (en) | 1,3-dioxolans with antitussive activity | |
| DE60017084D1 (de) | Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung | |
| RU2007103547A (ru) | Новые производные миндальной кислоты и их применение в качестве ингибиторов тромбина | |
| RU2008105976A (ru) | Способы получения ингибиторов полимеразы вируса гепатита с (hcv) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF | Valid on the event date | ||
| OU02 | Decision according to article 73(2) ipa 1992, publication of decision on partial fulfilment of the invention and change of patent claims |
Effective date: 20050624 |
|
| SP73 | Change of data on owner |
Owner name: DOMPE PHA.R.MA S.P.A.; IT Effective date: 20060613 |
|
| SP73 | Change of data on owner |
Owner name: DOMPE' FARMACEUTICI S.P.A.; IT Effective date: 20150928 |
|
| KO00 | Lapse of patent |
Effective date: 20170411 |